Controversies concerning the importance of genetic polymorphism in IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 17, Issue 4, 2002, Pages 542-545

  Frimat, Luc ^a,b   Kessler, Michèle ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; LECTIN; MANNOSE BINDING PROTEIN;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLOMERULOSCLEROSIS; HETEROZYGOTE; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; MULTIFACTORIAL GENETIC DISORDER; PATHOGENESIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0036222515     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.4.542     Document Type: Article

References (18)

1. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23
2. Evidence for genetic factors in the development and progression of IgA nephropathy
3. Association studies, ACE polymorphisms and renal disease
4. Polymorphism of angiotensin converting enzyme, angiotensinogen and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy. IGARAS: A study of 274 men
5. Insertion/deletion polymorphism in ACE gene is not associated with renal progression in Japanese patients with IgA nephropathy
6. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy
7. Genetic dissection of complex traits
8. Interpretation of results from genetic studies of multifactorial diseases
9. Studying the causes of kidney disease in humans: A review of methodologic obstacles and possible solutions
10. IgA nephropathy: Recent developments
11. What do we really know about the long-term prognosis of IgA-nephropathy?
12. Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors
13. Polymorphisms in the promoter region and at codon 54 of the MBL2 gene are not associated with IgA nephropathy
14. Frequency of mesangial IgA deposits in a nonselected autopsy series
15. Alleles of the α1 immunoglobulin gene 3′ enhancer control evolution of IgA nephropathy toward renal failure
16. Polymorphism in promoter region of Fcα receptor gene in patients with IgA nephropathy
17. Evolving methods in genetic epidemiology III. Gene-environment interaction in epidemiologic research
18. Will genetics revolutionize medicine?